Split History
ETFs Holding TPIV »    TPIV Historical Stock Prices »
Video: What is a Stock Split?

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Marker Therapeutics is a clinical-stage immuno-oncology company. Co. focuses on the development of peptide and gene-based immunotherapeutics and vaccines for the treatment of cancer and metastatic disease, as well as develops DNA expression technology. Co. is developing vaccines that target candidate breast cancer(s), colorectal cancer(s), ovarian cancer(s) and non-small cell lung cancer(s). Co.'s three primary technology platforms include: a licensed vaccine for the treatment of HER2/neu+ breast cancer; a licensed vaccine for treating breast and ovarian cancers; and a wholly owned DNA expression vaccine technology (Polystart) for treating various cancers or infectious disease. According to our TPIV split history records, TPIV has had 1 split.
TPIV split history picture
TPIV (TPIV) has 1 split in our TPIV split history database. The split for TPIV took place on July 27, 2009. This was a 1 for 10 reverse split, meaning for each 10 shares of TPIV owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 100 share position following the split.

When a company such as TPIV conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the TPIV split history from start to finish, an original position size of 1000 shares would have turned into 100 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into TPIV shares, starting with a $10,000 purchase of TPIV, presented on a split-history-adjusted basis factoring in the complete TPIV split history. TPIV split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 06/21/2011
End date: 10/17/2018
Start price/share: $0.20
End price/share: $8.34
Dividends collected/share: $0.00
Total return: 4,070.00%
Average Annual Total Return: 66.37%
Starting investment: $10,000.00
Ending investment: $417,068.43
Years: 7.33
Date Ratio
07/27/20091 for 10
TPIV is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

TRL Split History
TRNX Split History
TROV Split History
TRXC Split History
TTNP Split History
TTPH Split History
UHS Split History
UNIS Split History
USPH Split History
UTHR Split History

Also explore: TPIV shares outstanding history

BetaPro NASDAQ-100 2x Daily Bull ETF (HQU)
BetaPro S&P 500 2x Daily Bull ETF (HSU)
BetaPro S&P/TSX Capped Energy 2x Daily Bull ETF (HEU)
BetaPro S&P/TSX Capped Financials 2x Daily Bull ETF (HFU)
BetaPro S&P/TSX 60 2x Daily Bull ETF (HXU)
BetaPro Crude Oil Leveraged Daily Bull ETF (HOU)
Horizons Big Data & Hardware Index ETF (HBGD.U)
Horizons Big Data & Hardware Index ETF (HBGD)
Horizons NASDAQ-100 Index ETF (HXQ.U)
Horizons NASDAQ-100 Index ETF (HXQ)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

TPIV Split History | www.SplitHistory.com | Copyright © 2013 - 2021, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.